Search Results

Guidepoint recently launched Guidepoint Qsight -- an alternative data-driven product line that provides clients with a unique understanding of sector and individual company performance.

Guidepoint Qsight’s proprietary healthcare data sets, now operating under the name of Qsight Alpha, proved more accurate than 3Q19 consensus estimates to reported U.S. sales for 16 of 17 company models.

AxisPoint Health, an HGS company and a leader in population health management, today announced that it has earned URAC reaccreditation in Health Call Center for its GuidePoint solution, a clinically and analytically driven nurse advice, navigation, and member engagement service

Revance Therapeutics, Inc. (NASDAQ: RVNC), today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.

Revance Therapeutics, Inc., reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announces the strengthening of its management team with a new hire and a promotion in its vaccine development program, and the hiring of a veteran clinical trial project manager for its Phase II GEN-1 immunotherapy study in advanced ovarian cancer.

Celsion Corporation today announced financial results for the year ended December 31, 2021, and provided an update.

With one internet search, a patient can find a host of information and marketing materials touting the purported benefits of laser surgery.